Maehle L - Search Results

1

Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.

Sjursen W, Haukanes BI, Grindedal EM, Aarset H, Stormorken A, Engebretsen LF, Jonsrud C, Bjørnevoll I, Andresen PA, Ariansen S, Lavik LA, Gilde B, Bowitz-Lothe IM, Maehle L, Møller P. Sjursen W, et al. Among authors: maehle l. J Med Genet. 2010 Sep;47(9):579-85. doi: 10.1136/jmg.2010.077677. Epub 2010 Jun 28. J Med Genet. 2010. PMID: 20587412 Free PMC article.

2

[Hereditary breast cancer in Norway].

Heimdal K, Apold J, Maehle L, Dørum A, Møller P. Heimdal K, et al. Among authors: maehle l. Tidsskr Nor Laegeforen. 1999 Oct 30;119(26):3929-32. Tidsskr Nor Laegeforen. 1999. PMID: 10592755 Review. Norwegian.

3

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.

Borg A, Dørum A, Heimdal K, Maehle L, Hovig E, Møller P. Borg A, et al. Among authors: maehle l. Dis Markers. 1999 Oct;15(1-3):79-84. doi: 10.1155/1999/278269. Dis Markers. 1999. PMID: 10595257 Free PMC article.

4

Costs and benefits of diagnosing familial breast cancer.

Heimdal K, Maehle L, Møller P. Heimdal K, et al. Among authors: maehle l. Dis Markers. 1999 Oct;15(1-3):167-73. doi: 10.1155/1999/751892. Dis Markers. 1999. PMID: 10595273 Free PMC article.

5

The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.

Møller P, Borg A, Heimdal K, Apold J, Vallon-Christersson J, Hovig E, Maehle L; Norwegian Inherited Breast Cancer Group; Norwegian Inherited Ovarian Cancer Group. Møller P, et al. Among authors: maehle l. Eur J Cancer. 2001 May;37(8):1027-32. doi: 10.1016/s0959-8049(01)00075-2. Eur J Cancer. 2001. PMID: 11334729

6

Genetic epidemiology of BRCA1 mutations in Norway.

Møller P, Heimdal K, Apold J, Fredriksen A, Borg A, Hovig E, Hagen A, Hagen B, Pedersen JC, Maehle L; Norwegian Inherited Breast Cancer Group; Norwegian Inherited Ovarian Cancer Group. Møller P, et al. Among authors: maehle l. Eur J Cancer. 2001 Dec;37(18):2428-34. doi: 10.1016/s0959-8049(01)00299-4. Eur J Cancer. 2001. PMID: 11720839

7

The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

Heimdal K, Maehle L, Apold J, Pedersen JC, Møller P. Heimdal K, et al. Among authors: maehle l. Eur J Cancer. 2003 Oct;39(15):2205-13. doi: 10.1016/s0959-8049(03)00548-3. Eur J Cancer. 2003. PMID: 14522380

8

Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.

Geirdal AØ, Reichelt JG, Dahl AA, Heimdal K, Maehle L, Stormorken A, Møller P. Geirdal AØ, et al. Among authors: maehle l. Fam Cancer. 2005;4(2):121-6. doi: 10.1007/s10689-004-7995-y. Fam Cancer. 2005. PMID: 15951962

9

[Hereditary breast cancer].

Møller P, Maehle L, Apold J. Møller P, et al. Among authors: maehle l. Tidsskr Nor Laegeforen. 2005 Nov 17;125(22):3136-8. Tidsskr Nor Laegeforen. 2005. PMID: 16299574 Free article. Norwegian.

10

Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutation.

Geirdal AØ, Maehle L, Heimdal K, Stormorken A, Møller P, Dahl AA. Geirdal AØ, et al. Among authors: maehle l. Qual Life Res. 2006 Apr;15(3):461-70. doi: 10.1007/s11136-005-3008-3. Qual Life Res. 2006. PMID: 16547785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page